The Effect of Samul-tanggahyangbuja on Anti-Depressive Behavior and Immunity

키워드

참고문헌 (51)

1. Simpson ER, "34 Minireview : aromatase and the regulation of estrogen biosynthesis-some new perspectives", Endocrinology, 142(11), pp.4589~4594 (2001)
2. Dennerstein L, "New findings from non-linear longitudinal modelling of menopausal hormone changes", Hum Reprod Update, 13(6), pp.551~557 (2007)
3. Rubinow DR, "Estrogen-serotonin interactions : implications for affective regulation", Biol Psychiatry, 44, pp.839~850 (1998)
4. Joffe H, "Estrogen, serotonin and mood disturbance : where is the therapeutic bridge?", Biol Psychiatry, 44, pp.798~811 (1998)
5. Cohen LS, "Diagnosis and management of mood disorders during the menopausal transition", Am J Med, 118(Suppl 12B), pp.93~97 (2005)
6. Zweifel JE, "Meta-analysis of the effect of hormone replacement therapy upon depressed mood", Psychoneuroendocrinology, 22, pp.189~212 (1997)
7. Weissman MM, "Affective disorders", pp.53~80 (1991), The Free Press
8. Shors TJ, "Estrogen-mediated effects on depression and memory formation in females", J Affect Disord, 74(1), pp.85~96 (2003)
9. Desmond NL, "Ovarian steroidal control of connectivity in the female hippocampus : an overview of recent experimental findings and speculations on its functional consequences", Hippocampus, 7(2), pp.239~245 (1997)
10. Smith CC, "The estrous cycle and pituitary-ovarian function in Lewis and Fischer rats", Neuroimmunomodulation, 1(4), pp.231~235 (1994)
11. Woolley CS, "Effects of estrogen in the CNS", Curr Opin Neurobiol, 9(3), pp.349~354 (1999)
12. Cutter WJ, "Oestrogen, brain function, and neuropsychiatric disorders", J Neurol Neurosurg Psychiatry, 74(7), pp.837~840 (2003)
13. Ryan J, "A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women", Menopause, 16(3), pp.509~517 (2009)
14. Dowlati Y, "A meta-analysis of cytokines in major depression", Biol Psychiatry, 67(5), pp.446~457 (2010)
15. Irwin MR, "Depressive disorders and immunity : 20 years of progress and discovery", Brain Behav Immun, 21, pp.374~383 (2007)
16. O'Brien SM, "Impact of gender and menstrual cycle phase on plasma cytokine concentrations", Neuroimmunomodulation, 14(2), pp.84~90 (2007)
17. Xie M, "Modern study of the medical formulae in traditional chinese medicine", pp.25~30 (1997), Xue Yue Press
18. Lee SI, "TianJin Prescription Commentary", pp.53~60 (1987), Seougbosa
19. Sheng YX, "Simultaneous determination of gallic acid, albiflorin, paeoniflorin, ferulic acid and benzoic acid in Si-Wu decoction by high-performance liquid chromatography DAD method", J Pharm Biomed Anal, 37, pp.805~810 (2005)
20. Graf E, "Antioxidant potential of ferulic acid", Free Radic Biol Med, 13, pp.435~448 (1992)
21. Scott BC, "Evaluation of the antioxidant actions of ferulic acid and catechins", Free Radic Res Commun, 19, pp.241~253 (1993)
22. Yan JJ, "Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice", Prog Neuropsychopharmacol Biol Psychiatry, 28, pp.25~30 (2004)
23. Rodgers RJ, "Anxiety, defense and the elevated plus-maze", Neurosci Behav Rev, 21, pp.801~810 (1997)
24. Burger HG, "Hormonal changes in the menopause transition", Recent Prog Horm Res, 57, pp.257~275 (2002)
25. Freeman EW, "Associations of hormones and menopausal status with depressed mood in women with no history of depression", Arch Gen Psychiatry, 63(4), pp.375~382 (2006)
26. Dennerstein L, "Mood and the menopausal transition", J Nerv Ment Dis, 187(11), pp.685~691 (1999)
27. McKinlay JB, "The relative contributions of endocrine changes and social circumstances to depression in mid-aged women", J Health Soc Behav, 28(4), pp.345~363 (1987)
28. Porter M, "A population based survey of women’s experience of the menopause", Br J Obstet Gynaecol, 103(10), pp.1025~1028 (1996)
29. Dennerstein L, "A populationbased study of depressed mood in middle-aged, Australian-born women", Menopause, 11(5), pp.563~568 (2004)
30. Bellipanni G, "Effects of melatonin in perimenopausal and menopausal women : our personal experience", Ann NY Acad Sci, 1057, pp.393~402 (2005)
31. Peter Macinta, "Herbal medicines for menopausal symptoms", Drug Ther Bull, 47(1), pp.2~6 (2009)
32. Chen SW, "Taepyeonghyeminhwajegukbang", pp.310~311 (1985), People's Health Publishers
33. Choi IY, "Anti-inflammatory effect of Samul-tang in human mast cell line HMC-1", Oriental Pharmacy and Experimental Medicine, 6(3), pp.237~244 (2006)
34. Cho BW, "Effects of a constituent herbs of samul-tang on antithrombosis and antistress", The Journal of Oriental Gynecology, 12(2), pp.41~74 (1999)
35. Lim SL, "A study on effects of samu l-tang and samul-tang composition on leucopenia, thrombocytopenia and anemia", D. J. Univ. O. Med. J, 8(1), pp.837~838 (1999)
36. Hwang YM, "An experimental study on the effects of raw, dried and steamed roots of rehmanniae glutinosa on cell-mediated and humoral immune response in mice", K. H. Univ. O. Med. J, 10, pp.207~218 (1987)
37. Chen SW, "The effects of angelica essential oil in three murine tests of anxiety", Pharmacol Biochem Behav, 79(2), pp.377~382 (2004)
38. Matsumoto K, "Effects of methylenechloride-soluble fraction of japanese angelica root extract, ligustilide and butylidenephthalide on pentobarbital sleep in grouphoused and socially isolated mice", Life Sci, 62(23), pp.2073~2082 (1998)
39. 강지현, "천궁의 GABAA-benzodiazepine 수용체 복합체와의 상호작용", 생물치료정신의학, 3(2), pp.169~176 (1997), 대한생물치료정신의학회
40. Liu TP, "Stimulatory effect of paeoniflorin on the release of noradrenaline from ileal synaptosomes of guinea-pig in-vitro", J Pharm Pharmacol, 54(5), pp.681~688 (2002)
41. Kim SH, "Antidepressant effect of chaihu-shugan-san extract and its constituents in rat models of depression", 76(11), pp.1297~1306 (2005), Department of Neuropsychiatry. College of Medicine, Inje University
42. Crabbe JC, "Genetics of mouse behavior: interactions with laboratory environment", Science, 284(5420), pp.1670~1672 (1999)
43. Hogg S, "A review of the validity and variability of the elevated plus-maze as an animal model of anxiety", Pharmacol Biochem Behav, 54, pp.21~30 (1996)
44. Korte SM, "A robust animal model of state anxiety: fear-potentiated behaviour in the elevated plus-maze", Eur J Phamacol, 463(1-3), pp.163~175 (2003)
45. Birkhauser M, "Depression, menopause and estrogens: is there a correlation?", Maturitas, 41, pp.S3~S8 (2002)
46. Andrade TG, "Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors", Behav Brain Res, 163(1), pp.18~25 (2005)
47. Maayan R, "The effect of 17beta estradiol withdrawal on the level of brain and peripheral neurosteroids in ovarectomized rats", Neurosci Lett, 384(1-2), pp.156~161 (2005)
48. Dantzer R, "From inflammation to sickness and depression : when the immune system subjugates the brain", Nat Rev Neurosci, 9(1), pp.46~56 (2008)
49. Sutcigil L, "Pro- and antiinflammatory cytokine balance in major depression: effect of sertraline therapy", Clinical and Developmental Immunology, pp.1~6 (2007)[DOI]
50. Heneka MT, "Locus coeruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine", Proc Natl Acad Sci USA, 107, pp.6058~6063 (2010)
51. Kageyama K, "Regulatory mechanisms underlying corticotropin -releasing factor gene expression in the hypothalamus", Endocr J, 56(3), pp.335~344 (2009)

관련 논문AI추천